Page last updated: 2024-10-17

n(1)-methylnicotinamide and Ventricular Dysfunction, Left

n(1)-methylnicotinamide has been researched along with Ventricular Dysfunction, Left in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, M1
He, A1
Chu, J1
Chen, C1
Zhang, S1
He, Y1
Tao, W1
Lu, M1
Hua, M1
Ju, W1
Fang, Z1

Other Studies

1 other study available for n(1)-methylnicotinamide and Ventricular Dysfunction, Left

ArticleYear
Serum N
    Scientific reports, 2018, 06-05, Volume: 8, Issue:1

    Topics: Aged; Asian People; China; Chromatography, Liquid; Coronary Artery Disease; Echocardiography, Dopple

2018